The ASX growth share space is a great place to find ideas that can help us outperform the wider stock market.
The smaller we go down the market capitalisation list, the more likely it is to find an undervalued business with a long growth runway, in my opinion.
Experts from the listed investment company (LIC) WAM Research Ltd (ASX: WAX) have outlined two businesses that could be ones to watch. The LIC looks for the most compelling, undervalued growth opportunities on the ASX.
Image source: Getty Images
Civmec Ltd (ASX: CVL)
WAM described Civmec as a founder-led, mining, construction and engineering services company based in Western Australia.
During June, the company announced its order book had reached $1.5 billion. Growth was supported by a series of new contract awards, panel agreement extensions and new orders across its resources, infrastructure, energy and maintenance activities.
Key project wins included a further package of work with Iluka Resources Ltd (ASX: ILU) at the Eneabba Rare Earths Refinery and the major construction contract for Perth Park, delivered through an alliance with Seymour Whyte and Aurecon.
The investment team at WAM believes these projects provide strong earnings visibility over the next two years. Wilson Asset Management also believes that the ASX growth share is well positioned to win significant defence contracts which are expected to come to market over the next two to three years.
WAM suggested that Vicmec's ownership of strategic land at the Henderson precinct in Western Australia positions it well in tendering for these projects.
Reliance Worldwide Corporation Ltd (ASX: RWC)
The other ASX growth share that was highlighted in the WAM Research portfolio was plumbing supplies company Reliance, which has operations across Australia, Europe and North America.
WAM noted that during June, it announced the next stage of streamlining its manufacturing operations.
That plan includes the closure of its brass casting, forging and machining operations in Moorabbin and Braeside, Melbourne, along with additional smaller sites.
Those changes are expected to deliver a benefit to net annual operating profit (EBITDA) of approximately US$9 million across the group by the end of FY27.
WAM said the ASX growth share has suffered headwinds in recent years, including US tariffs and higher interest rates, but the investment team believe the outlook is improving as macroeconomic indicators begin to stabilise and the company resets its cost base.
In WAM's view, this positions Reliance to grow earnings into FY27 and FY28. The fund manager sees potential for a rerating in the Reliance share price as earnings momentum improves.
